4-Antibody AG. (8/16/11). "Press Release: 4-Antibody AG Forms Collaboration with Human Genome Sciences". Basel.

	Organisation	4-Antibody AG
	Group	4-Antibody (Group)
	Organisation 2	Human Genome Sciences (HGSI) (Group)
	Today	GlaxoSmithKline (GSK) (Group)
	Group	GlaxoSmithKline (GSK) (Group)
	Product	MAb, human, fully
	Product 2	antibody technology
	Index term 2	4-Antibody–College Group: public relations, 201109 service existent by College Hill Life Sciences
	Person	Burns, Robert F. (4-Antibody 201101– CEO before Affitech CEO before Celldex Therapeutics CEO)
	Person 2	Mayer, Robert (College Group 201205 Account Director College Hill Life Sciences Munich before Northbank Communications)

4-Antibody AG today announced the signing of a collaboration agreement with Human Genome Sciences (HGS) to discover and develop fully human therapeutic antibodies. Financial terms of the deal were not disclosed.

The collaboration with HGS is focused on 4-Antibody's proprietary high throughput in vitro Retrocyte Display® technology for rapid discovery of fully human antibodies against novel targets nominated by HGS. The Retrocyte Display® technology (Retroviral B lymphocyte Display) is a potent and fast tool for high quality therapeutic antibody discovery and optimization using a rapid flow cytometry approach. Full-length immunoglobulin antibody libraries are expressed in mammalian B-lineage cells, the cell designed by nature for optimal antibody display, resulting in 'better-behaved', fully human antibodies. This collaboration agreement, which initially involves two projects, is 4-Antibody's second such alliance with a pharmaceutical partner, the first being with Boehringer Ingelheim which commenced in early 2010.

Dr Robert Burns, 4-Antibody's CEO, said: "We're delighted to announce our second collaboration with an established pharmaceutical partner. Collaborations serve an important role in validating our Retrocyte Display® technology platform and we're delighted that HGS wanted to enter into this Multi-target collaboration with us. This adds an additional momentum to our other ongoing partnering activities."

- ends -

Further Information:

Dr Robert Burns
CEO
4-Antibody AG
t: +41-61-633-20-60
e: robert.burns@4-antibody.com

Dr Robert Mayer
Account Manager
College Hill
t: +49-89-5238-8030
e: robert.mayer@collegehill.com

About 4-Antibody AG

4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform which is generating an emerging pipeline of antibody therapeutics. The proprietary discovery engine is the in vitro Retrocyte Display® technology, a fast and highly efficient source of antibody drug candidates. Retrocyte Display® generates high quality therapeutic antibody drug candidates quickly using a rapid, high-throughput, flow cytometry approach incorporating fulllength IgG format human antibody libraries expressed in mammalian B cells. 4-Antibody provides access to its technologies to select pharmaceutical R&D collaborators and is also generating an inhouse pipeline of antibody drugs. The Company's lead development product is an anticytomegalovirus antibody drug. 4-Antibody is a private company with strong, commerciallyexperienced leadership located in Basel, Switzerland and Jena, Germany.

For more information please visit: www.4-antibody.com

*** 4-Antibody moves to new offices and labs***

Please note the new address and phone number of our Basel operation:
4-Antibody AG
Hochbergerstrasse 60C
CH-4057 Basel, Switzerland
Phone: +41-61-633-20-60

About Human Genome Sciences

Human Genome Sciences exists to place new therapies into the hands of those battling serious disease. For more information about HGS, please visit the Company's web site at www.hgsi.com .

4-Antibody AG
Hochbergerstrasse 60C
CH-4057 Basel, Switzerland
Phone: +41-61-633-2260
ir@4-antibody.com
www.4-antibody.com

Record changed: 2011-11-25

Top News

Upcoming Events

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Partners

4-Antibody AG. (8/16/11). "Press Release: 4-Antibody AG Forms Collaboration with Human Genome Sciences". Basel.

More documents for 4-Antibody (Group)